期刊文献+

男性结直肠癌术后勃起功能障碍治疗体会

Experience in the treatment of erectile dysfunction in male patients with colorectal cancer
下载PDF
导出
摘要 目的探讨男性结直肠癌术后勃起功能障碍的治疗效果。方法对88例接受结直肠癌手术的男性肿瘤患者,术后服用他达拉非片。以国际勃起功能指数问卷为评价指标,采用问卷调查的方式,由患者自行或者电话回访填写,对比治疗前后的疗效。结果经过3个月的治疗,结肠癌患者治疗后评分为(18.82±1.13)分,直肠癌患者治疗后评分为(15.15±1.67)分,两者治疗前后均有显著性差异(P<0.05)。结肠癌术后勃起功能障碍治疗有效率为65.85%,直肠癌为53.19%。结论男性结直肠癌患者术后服用他达拉非片临床疗效较好,能显著改善术后勃起功能,提升患者生活质量。 Objective To discuss the treatment effect of erectile dysfunction in male patients with colorectal cancer postoperative. Methods Eighty-eight cases of male cancer patients undergoing colorectal surgery were selected and the patients all took tadalafil postoperative. Using international index of erectile function questionnaire as evaluation index, curative effect of before and after treatment was compared with the method of questionnaire survey, which was filled in by the patients themselves or telephone return visit. Results After three months of treatment, the score of patients with colon cancer after treatment was (18.82±1.13) points, and rectal cancer patients" score was (15.15±1.67) points, both of the above score were significantly different from before (P〈0.05). Conclusion Tadalafil tablets in treating male patients with colorectal cancer after surgery has a good clinical curative effect, and it can significantly improve the postoperative erectile function and the quality of life of patients.
出处 《临床医学研究与实践》 2016年第19期61-62,共2页 Clinical Research and Practice
关键词 结直肠癌 勃起功能障碍 国际勃起功能指数 他达拉非片 colorectal cancer erectile dysfunction international index of erectile function tadalafil
  • 相关文献

参考文献5

二级参考文献54

  • 1Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
  • 2Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 1982; 69:613-616.
  • 3Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983; 52:1317-1329.
  • 4Prolongation of the ctisease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985; 312:1465-1472.
  • 5NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264:1444-1450.
  • 6Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, Nilsen JB, Wist E, Hannisdal E. Randomized controlled trial of postoperative radiotherapy and short- term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 1997; 84: 1130-1135.
  • 7Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324:709-715.
  • 8Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA 1988; 259:3571-3578.
  • 9Gerard A, Buyse M, Nordlinger B, Loygue J, P.PAne F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208:606-614.
  • 10Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336:980-987.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部